EHEBHomo sapiens (Human)Transformed cell line

🤖 AI SummaryBased on 1 publications

Quick Overview

EHEB is a human B-cell chronic lymphocytic leukemia cell line with normal karyotype and Ig gene rearrangements.

Detailed Summary

EHEB is a human B-cell chronic lymphocytic leukemia (B-CLL) cell line established from a patient's blood. It has a normal karyotype and exhibits immunoglobulin (Ig) gene rearrangements consistent with the neoplastic clone. The cell line maintains CD5 positivity and shows specific surface and intracellular immunoglobulin expression patterns. EHEB is useful for studying B-CLL biology, immunoglobulin gene rearrangements, and EBV transformation processes. Its normal karyotype makes it a valuable model for understanding clonal evolution and genetic stability in CLL.

Research Applications

Immunoglobulin gene rearrangement analysisB-cell chronic lymphocytic leukemia (B-CLL) researchEBV transformation studiesClonal evolution and genetic stability in CLL

Key Characteristics

Normal karyotypeCD5 positivityIg gene rearrangementsSurface and intracellular immunoglobulin expression
Generated on 6/16/2025

Basic Information

Database IDCVCL_1194
SpeciesHomo sapiens (Human)
Tissue SourcePeripheral blood[UBERON:UBERON_0000178]

Donor Information

Age69
Age CategoryAdult
SexFemale

Disease Information

DiseaseB-Lymphoblastic Leukemia/Lymphoma
LineageLymphoid
SubtypeB-Lymphoblastic Leukemia/Lymphoma
OncoTree CodeBLL

DepMap Information

Source TypeDSMZ
Source IDACH-000038_source

Haplotype Information (STR Profile)

Short Tandem Repeat (STR) profile for cell line authentication.

Amelogenin
X
CSF1PO
10
D13S317
13
D16S539
9,12
D18S51
12,14
D19S433
13
D21S11
30.2,31.2
D2S1338
23,25
D3S1358
16,18
D5S818
12
D7S820
10,11
D8S1179
13
FGA
22,24
Penta D
9,15
Penta E
5,11
TH01
6
TPOX
8,9
vWA
16
Gene Expression Profile
Gene expression levels and statistical distribution
Loading cohorts...
Full DepMap dataset with combined data across cell lines

Loading gene expression data...

Publications

Next-generation characterization of the Cancer Cell Line Encyclopedia.

Sellers W.R.

Nature 569:503-508(2019).

An interactive resource to probe genetic diversity and estimated ancestry in cancer cell lines.

Dutil J., Chen Z.-H., Monteiro A.N.A., Teer J.K., Eschrich S.A.

Cancer Res. 79:1263-1273(2019).

Screening human cell lines for viral infections applying RNA-Seq data analysis.

Uphoff C.C., Pommerenke C., Denkmann S.A., Drexler H.G.

PLoS ONE 14:E0210404-E0210404(2019).

Profiling the B/T cell receptor repertoire of lymphocyte derived cell lines.

Yang H.H., Koeffler H.P.

BMC Cancer 18:940.1-940.13(2018).

Characterization of human cancer cell lines by reverse-phase protein arrays.

Liang H.

Cancer Cell 31:225-239(2017).

A landscape of pharmacogenomic interactions in cancer.";

Wessels L.F.A., Saez-Rodriguez J., McDermott U., Garnett M.J.

Cell 166:740-754(2016).

TCLP: an online cancer cell line catalogue integrating HLA type, predicted neo-epitopes, virus and gene expression.

Loewer M., Sahin U., Castle J.C.

Genome Med. 7:118.1-118.7(2015).

Molecular characterization of neoplastic and normal 'sister' lymphoblastoid B-cell lines from chronic lymphocytic leukemia.

Jurlander J., Klein E., Weit N., Herling M., Rosenquist R., Rosen A.

Leuk. Lymphoma 54:1769-1779(2013).

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.

Morrissey M.P., Sellers W.R., Schlegel R., Garraway L.A.

Nature 483:603-607(2012).

Detection of EBV, HBV, HCV, HIV-1, HTLV-I and -II, and SMRV in human and other primate cell lines.

Uphoff C.C., Denkmann S.A., Steube K.G., Drexler H.G.

J. Biomed. Biotechnol. 2010:904767.1-904767.23(2010).

Signatures of mutation and selection in the cancer genome.";

Deloukas P., Yang F.-T., Campbell P.J., Futreal P.A., Stratton M.R.

Nature 463:893-898(2010).

False leukemia-lymphoma cell lines: an update on over 500 cell lines.

Drexler H.G., Dirks W.G., Matsuo Y., MacLeod R.A.F.

Leukemia 17:416-426(2003).

Resistance to 2-chloro-2'-deoxyadenosine of the human B-cell leukemia cell line EHEB.

Ferrant A., Van den Berghe G., Bontemps F.

Clin. Cancer Res. 7:3559-3566(2001).

Establishment of a karyotypically normal B-chronic lymphocytic leukemia cell line; evidence of leukemic origin by immunoglobulin gene rearrangement.

Saltman D.L., Bansal N.S., Ross F.M., Ross J.A., Turner G., Guy K.

Leuk. Res. 14:381-387(1990).

The leukemia-lymphoma cell line factsbook.";

Drexler H.G.

(In book) ISBN 9780122219702; pp.1-733; Academic Press; London; United Kingdom (2001).

Web Resources